Progressive Muscular Dystrophies (PMDs) are a heterogeneous family of neuromuscular diseases. Although they are considered as a rare diseases group, their severity and relatively high prevalence make them a suitable target for that kind of scientific research whose target is to give to the community a better quality of life. With this in mind, it is reasonable to think that a reliable predictive model is needed. Alas, since both PMDs subtypes prevalence and incidence among general population do not show significant statistical variations, it is not possible to base a predictive model on these data. However, the aim of this paper is to elaborate a novel approach in order to crack the code of PMDs unpredictability.
GSL Journal of Public Health and Epidemiology
D Frumento
2019-01-01
Abstract
Progressive Muscular Dystrophies (PMDs) are a heterogeneous family of neuromuscular diseases. Although they are considered as a rare diseases group, their severity and relatively high prevalence make them a suitable target for that kind of scientific research whose target is to give to the community a better quality of life. With this in mind, it is reasonable to think that a reliable predictive model is needed. Alas, since both PMDs subtypes prevalence and incidence among general population do not show significant statistical variations, it is not possible to base a predictive model on these data. However, the aim of this paper is to elaborate a novel approach in order to crack the code of PMDs unpredictability.File | Dimensione | Formato | |
---|---|---|---|
2019 Sarcoglycanopathies a novel predictive approach.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
170.52 kB
Formato
Adobe PDF
|
170.52 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.